Antimycobacterial activity of Citrullus colocynthis (L.) Schrad. against drug sensitive and drug resistant Mycobacterium tuberculosis and MOTT clinical isolates
- PMID: 23816500
- DOI: 10.1016/j.jep.2013.06.022
Antimycobacterial activity of Citrullus colocynthis (L.) Schrad. against drug sensitive and drug resistant Mycobacterium tuberculosis and MOTT clinical isolates
Abstract
Ethnopharmacological relevance: Citrullus colocynthis (Cucurbitaceae), a folk herbal medicine and traditionally used natural remedy for tuberculosis in India has been studied to validate its antitubercular activity against drug sensitive and drug resistant (including multidrug resistant) Mycobacterium tuberculosis and Mycobacterium other than tuberculosis (MOTT) bacilli.
Materials and methods: Inhibitory and bactericidal activities of crude extracts, fractions and compounds of Citrullus colocynthis plant, consisting of aerial parts and ripe deseeded fruits were performed against the drug sensitive standard strain of Mycobacterium tuberculosis H37Rv (ATCC 27294), 16 drug resistant strains of Mycobacterium tuberculosis and two MOTT strains, using radiometric BACTEC 460TB system.
Results: Methanolic extract of ripe deseeded fruit of Citrullus colocynthis has shown good activity (MIC ≤ 62.5 µg/ml), whereas among the bioactive fractions, FC IX demonstrated the best activity (MIC 31.2 µg/ml) against Mycobacterium tuberculosis H37Rv. Bioactive FC III, IX and X also inhibited 16 clinical isolates of Mycobacterium tuberculosis consisting of seven non-multidrug resistants, eight multidrug resistants, one extensively drug resistant and two of MOTTs with MICs in the range of 50-125, 31.2-125 and 62.5-125 µg/ml, respectively. Ursolic acid and cucurbitacin E 2-0-β-d-glucopyranoside were identified as the main biomarkers active against Mycobacterium tuberculosis H37Rv (MICs 50 and 25 µg/ml respectively), as well as against the 18 clinical isolates. FC III and FC IX showed better inhibition of drug resistant and MOTT clinical isolates. Minimal bactericidal concentrations of extracts, fractions and compound C-2 were ≥ two-fold MIC values.
Conclusions: The study provides a scientific rationale for the traditional use of Citrullus colocynthis fruit in the treatment of tuberculosis. In addition, the study elucidates a broad spectrum antimycobacterial action of Citrullus colocynthis fruit, which can contribute to the development of improved preparation of an antitubercular natural drug for the treatment of drug resistant tuberculosis and MOTT infection as well.
Keywords: Citrullus colocynthis Cucurbitaceae; Drug resistant; Minimal bactericidal concentration.; Minimal inhibitory concentration; Mycobacterium other than tuberculosis (MOTT); Mycobacterium tuberculosis.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
The medicinal plants in the control of tuberculosis: Laboratory study on medicinal plants from the Northern Area of Pakistan.Int J Mycobacteriol. 2017 Jan-Mar;6(1):102-105. doi: 10.4103/ijmy.ijmy_11_17. Int J Mycobacteriol. 2017. PMID: 28317814
-
Naphthoquinones isolated from Diospyros anisandra exhibit potent activity against pan-resistant first-line drugs Mycobacterium tuberculosis strains.Pulm Pharmacol Ther. 2014 Feb;27(1):114-20. doi: 10.1016/j.pupt.2013.08.001. Epub 2013 Aug 20. Pulm Pharmacol Ther. 2014. PMID: 23968826
-
Antimycobacterial terpenoids from Juniperus communis L. (Cuppressaceae).J Ethnopharmacol. 2009 Dec 10;126(3):500-5. doi: 10.1016/j.jep.2009.09.007. Epub 2009 Sep 13. J Ethnopharmacol. 2009. PMID: 19755141
-
Citrullus colocynthis (L.) Schrad (bitter apple fruit): a review of its phytochemistry, pharmacology, traditional uses and nutritional potential.J Ethnopharmacol. 2014 Aug 8;155(1):54-66. doi: 10.1016/j.jep.2014.06.011. Epub 2014 Jun 14. J Ethnopharmacol. 2014. PMID: 24936768 Review.
-
Three promising antimycobacterial medicinal plants reviewed as potential sources of drug hit candidates against multidrug-resistant tuberculosis.Tuberculosis (Edinb). 2020 Sep;124:101987. doi: 10.1016/j.tube.2020.101987. Epub 2020 Aug 16. Tuberculosis (Edinb). 2020. PMID: 32841928 Review.
Cited by
-
The potential of plant systems to break the HIV-TB link.Plant Biotechnol J. 2019 Oct;17(10):1868-1891. doi: 10.1111/pbi.13110. Epub 2019 Jul 18. Plant Biotechnol J. 2019. PMID: 30908823 Free PMC article. Review.
-
Promising Lead Compounds in the Development of Potential Clinical Drug Candidate for Drug-Resistant Tuberculosis.Molecules. 2020 Dec 2;25(23):5685. doi: 10.3390/molecules25235685. Molecules. 2020. PMID: 33276545 Free PMC article. Review.
-
Plants Producing Ribosome-Inactivating Proteins in Traditional Medicine.Molecules. 2016 Nov 18;21(11):1560. doi: 10.3390/molecules21111560. Molecules. 2016. PMID: 27869738 Free PMC article. Review.
-
Molecular Docking Suggests the Targets of Anti-Mycobacterial Natural Products.Molecules. 2021 Jan 18;26(2):475. doi: 10.3390/molecules26020475. Molecules. 2021. PMID: 33477495 Free PMC article.
-
Natural-Product-Based Solutions for Tropical Infectious Diseases.Clin Microbiol Rev. 2021 Dec 15;34(4):e0034820. doi: 10.1128/CMR.00348-20. Epub 2021 Sep 8. Clin Microbiol Rev. 2021. PMID: 34494873 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous